• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

德尔福研究:晚期肾细胞癌和晚期肝细胞癌的核心患者报告结局。

A Delphi Study of Core Patient-Reported Outcomes for Advanced Renal Cell Carcinoma and Advanced Hepatocellular Carcinoma.

机构信息

Research Assistant, Oncology Advanced Nurse Practitioner, European Oncology Nursing Society (EONS), Brussels, Belgium.

Associate Professor, School of Nursing, Psychotherapy and Community Health, Dublin City University, Dublin, Ireland.

出版信息

Semin Oncol Nurs. 2023 Aug;39(4):151409. doi: 10.1016/j.soncn.2023.151409. Epub 2023 Apr 1.

DOI:10.1016/j.soncn.2023.151409
PMID:37012164
Abstract

OBJECTIVES

There is little research to help health care professionals understand what patient outcomes are considered a priority in advanced liver or kidney cancer. Knowing what is important to patients can help promote person-centered approaches to treatment and disease management. The aim of this study was to identify those patient-reported outcomes (PROs) that patients, carers, and health care professionals consider as "core" when providing care to those with advanced liver or kidney cancer.

DATA SOURCES

A three-round Delphi study was undertaken to ask experts by profession or experience to rank PROs identified from a previous literature review. Fifty-four experts, including people living with advanced liver or kidney cancer (44.4%), family members and caregivers (9.3%), and health care professionals (46.8%), reached consensus on 49 PROs including 12 new items (eg, palpitations, hopefulness, or social isolation). Items with the highest rate of consensus included quality of life, pain, mental health, and capacity to do daily activities.

CONCLUSION

People living with advanced liver or kidney cancer experience complex health care needs. Some important outcomes were not actually captured in practice in this population and were suggested as part of this study. There are discrepancies between the views of health care professionals, patients, and family in what is important, highlighting the need of using measures to facilitate communication.

IMPLICATIONS FOR NURSING PRACTICE

Identification of priority PROs reported here will be key to facilitate more focused patient assessments. The actual use of measures in cancer nursing practice to allow monitoring of PROs must be tested for feasibility and usability.

摘要

目的

针对晚期肝或肾肿瘤患者,医疗保健专业人员对哪些患者结果应作为优先事项知之甚少。了解患者的需求有助于促进以患者为中心的治疗和疾病管理方法。本研究旨在确定患者、护理人员和医疗保健专业人员在为晚期肝或肾肿瘤患者提供护理时认为“核心”的患者报告结果(PRO)。

资料来源

采用三轮德尔菲研究,要求专业或经验专家对从先前文献综述中确定的 PRO 进行排名。54 名专家(包括 44.4%的晚期肝或肾肿瘤患者、9.3%的家庭成员和护理人员以及 46.8%的医疗保健专业人员)就 49 项 PRO 达成共识,其中包括 12 项新条目(例如心悸、希望或社会隔离)。具有最高共识率的项目包括生活质量、疼痛、心理健康和日常活动能力。

结论

晚期肝或肾肿瘤患者的医疗保健需求复杂。该人群的实际实践中并未实际涵盖一些重要的结果,并且在本研究中提出了这些结果。医疗保健专业人员、患者和家庭在重要性方面的看法存在差异,这突显了使用措施促进沟通的必要性。

对护理实践的影响

此处确定的优先 PRO 将是促进更有针对性的患者评估的关键。必须测试在癌症护理实践中实际使用措施来监测 PRO 的可行性和可用性。

相似文献

1
A Delphi Study of Core Patient-Reported Outcomes for Advanced Renal Cell Carcinoma and Advanced Hepatocellular Carcinoma.德尔福研究:晚期肾细胞癌和晚期肝细胞癌的核心患者报告结局。
Semin Oncol Nurs. 2023 Aug;39(4):151409. doi: 10.1016/j.soncn.2023.151409. Epub 2023 Apr 1.
2
A rapid review of patient-reported outcomes investigated in the context of advanced renal cell cancer or advanced hepatocellular cancer.对在晚期肾细胞癌或晚期肝细胞癌背景下所研究的患者报告结局的快速综述。
Eur J Oncol Nurs. 2023 Apr;63:102241. doi: 10.1016/j.ejon.2022.102241. Epub 2022 Nov 16.
3
Consensus views on an advanced breast cancer education curriculum for cancer nurses: A Delphi study.癌症护士高级乳腺癌教育课程的共识观点:一项德尔菲研究。
Nurse Educ Today. 2023 May;124:105757. doi: 10.1016/j.nedt.2023.105757. Epub 2023 Feb 11.
4
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
5
Developing a core set of patient-reported outcomes in pancreatic cancer: A Delphi survey.制定一套胰腺癌患者报告结局的核心指标:德尔菲调查。
Eur J Cancer. 2016 Apr;57:68-77. doi: 10.1016/j.ejca.2016.01.001. Epub 2016 Feb 14.
6
Core set of patient-reported outcomes for myelodysplastic syndromes: an EUMDS Delphi study involving patients and hematologists.骨髓增生异常综合征患者报告结局核心集:一项涉及患者和血液学家的 EUMDS Delphi 研究。
Blood Adv. 2022 Jan 11;6(1):1-12. doi: 10.1182/bloodadvances.2021004568.
7
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
8
Patient-reported Outcome Measurement and Reporting for Patients with Advanced Renal Cell Carcinoma: A Systematic Literature Review.患者报告的晚期肾细胞癌患者结局测量和报告:系统文献回顾。
Eur Urol. 2023 Oct;84(4):406-417. doi: 10.1016/j.eururo.2023.07.006. Epub 2023 Aug 5.
9
Core Outcome Domains for Trials in Autosomal Dominant Polycystic Kidney Disease: An International Delphi Survey.常染色体显性遗传多囊肾病临床试验的核心结局指标:国际德尔菲调查。
Am J Kidney Dis. 2020 Sep;76(3):361-373. doi: 10.1053/j.ajkd.2020.01.005. Epub 2020 Apr 28.
10
Patient-Reported Outcomes to Achieve Person-Centered Care for Aging People With Kidney Disease.实现以患者为中心的老年肾脏病患者护理的患者报告结局。
Semin Nephrol. 2024 May-Jul;44(3-4):151548. doi: 10.1016/j.semnephrol.2024.151548. Epub 2024 Aug 23.

引用本文的文献

1
Wellbeing status and priority concerns of patients with advanced renal cell carcinoma: results of the EONS PROMs project international online survey.晚期肾细胞癌患者的健康状况及优先关注问题:EONS PROMs项目国际在线调查结果
Support Care Cancer. 2025 Jun 3;33(6):531. doi: 10.1007/s00520-025-09585-5.